Travere Therapeutics CFO Cline Christopher R. sold 642 shares at $66.37 each on September 2, 2026. Investors can use the transaction and his resulting ownership of 118,016 shares to track the executive’s disclosed position in the company.

Key Highlights

  • The transaction occurred on September 2, 2026.
  • Cline Christopher R. held 118,016 Travere Therapeutics shares after the sale.
  • The transaction record identifies Cline as Travere Therapeutics’ chief financial officer.

Travere Therapeutics, Inc. (NASDAQ: TVTX) saw Chief Financial Officer Cline Christopher R. sell 642 shares at $66.37 per share. The transaction took place on September 2, 2026. Cline’s post-transaction ownership stood at 118,016 shares.

Cline’s Post-Sale Travere Position

His remaining position was stated as 118,016 shares after the sale. The transaction involved 642 shares at $66.37 per share. The disclosed ownership figure reflects the executive’s position following that transaction.